Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China 2021-10-26 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
Antengene to Host its First R&D Days on November 16 and November 18, 2021 2021-10-25 20:00
Happiness Biotech Acquires Majority Ownership in Fujian Shennong 2021-10-25 20:00
GC Group strengthens Sustainable Growth for business and customers with "Together To Net Zero" Roadmap 2021-10-25 19:05
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer 2021-10-25 17:00
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer 2021-10-23 15:05
Technological supremacy reigns in Chengdu 2021-10-22 21:14
2021 Bio-enzyme Application Explorer Summit held in Chengdu 2021-10-22 14:23
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore 2021-10-22 09:00
Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution 2021-10-21 21:57
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates 2021-10-21 16:00
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray 2021-10-21 15:58
IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE 2021-10-21 10:31
Singapore-based Biosyngen receives 500 million yuan in investment 2021-10-21 09:30
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization 2021-10-20 22:34
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine 2021-10-20 21:24
1 178 179 180 181 182 415